Fennec Pharmaceuticals Inc. (FENC)

NASDAQ: FENC · Real-Time Price · USD

6.77

-0.26 (-3.70%)

At close: May 13, 2026, 4:00 PM EDT

6.75

-0.02 (-0.30%)

After-hours: May 13, 2026, 4:10 PM EDT

Fennec Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2014
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '14 Dec 31, 2014
Cash & Equivalents	36.79	26.63	13.27	2.31
Cash & Short-Term Investments	36.79	26.63	13.27	2.31
Cash Growth	38.12%	100.72%	475.16%	-
Accounts Receivable	23.22	12.88	8.81	-
Inventory	1.57	1.06	2.16	-
Other Current Assets	5.47	3.55	2.62	0.07
Total Current Assets	67.04	44.12	26.86	2.37
Other Long-Term Assets	3.51	0.82	0.01	-
Total Assets	70.55	44.95	26.86	2.37
Accounts Payable	4.64	3.24	3.78	-
Accrued Expenses	5.64	3.43	3.75	-
Current Portion of Leases	-	0	0.02	-
Unearned Revenue	0.25	0.25	-	-
Total Current Liabilities	10.52	6.92	7.55	0.44
Long-Term Debt	-	19.34	30.93	-
Other Long-Term Liabilities	24.56	24.56	0	1.32
Total Long-Term Liabilities	24.56	43.9	30.93	1.32
Total Liabilities	35.08	50.82	38.49	1.76
Common Stock	189.91	145.61	144.31	-
Additional Paid-in Capital	73.75	66.96	62.07	-
Accumulated Other Comprehensive Income	1.24	1.24	1.24	-
Retained Earnings	-229.42	-219.68	-219.25	-
Shareholders' Equity	35.47	-5.87	-11.62	0.61
Total Liabilities & Equity	70.55	44.95	26.86	2.37
Total Debt	0	19.34	30.95	0
Net Cash (Debt)	36.79	7.29	-17.68	2.31
Net Cash Growth	404.36%	-	-	-
Net Cash Per Share	1.29	0.27	-0.67	0.23
Book Value	35.47	-5.87	-11.62	0.61
Book Value Per Share	1.24	-0.22	-0.44	0.06
Tangible Book Value	35.47	-5.87	-11.62	0.61
Tangible Book Value Per Share	1.24	-0.22	-0.44	0.06

Updated Mar 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q